Clinical trials
Active, not recruiting Neuroblastoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 6 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 8 |
| 2019 | 9 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 56 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 9 |
| Memorial Sloan Kettering Cancer Center | 6 |
| Baylor College of Medicine | 4 |
| Children's Oncology Group | 4 |
| New Approaches to Neuroblastoma Therapy Consortium | 3 |
| Seattle Children's Hospital | 3 |
| Giselle Sholler | 2 |
| Nationwide Children's Hospital | 2 |
| St. Jude Children's Research Hospital | 2 |
| Bambino Gesù Hospital and Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroblastoma | 56 |
| Osteosarcoma | 17 |
| Sarcoma | 17 |
| Rhabdomyosarcoma | 15 |
| Medulloblastoma | 14 |
| Sarcoma, Ewing | 14 |
| Hepatoblastoma | 12 |
| Rhabdoid Tumor | 12 |
| Wilms Tumor | 12 |
| Ependymoma | 11 |
Trials
Showing 26 to 50 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.